Cryoport, Inc. (CYRX) is a leading provider of cryogenic logistics solutions to the life sciences industry, a key component in transporting products such as regenerative medicine, gene therapies, and vaccines. Founded in 1999, the California-based company provides critical temperature-controlled logistics services to biopharmaceutical, IVF, and surrogacy industries worldwide through a network of locations and logistics partners.
Known for its advanced tracking and monitoring capabilities, Cryoport's logistics platform capitalises on cutting-edge technology, such as cloud-based logistics management software. This enables real-time monitoring of the shipment's condition, making corrections as necessary to ensure the quality and safety of the transported material.
Cryoport utilizes scientific shipping containers capable of maintaining temperatures as low as -196°C, necessary for the transportation of biological materials, including cell therapies and vaccines. The company's robust 'chain of condition' and 'chain of custody' procedures demonstrate its commitment towards maintaining the viability of sensitive biological materials throughout the transportation process.
In recent years, Cryoport has experienced significant growth, fueled by the rise in cell and gene therapies. The launch of new therapies, combined with an increasing number of clinical trials around the world, propels demand for the company’s highly specialized logistics services. Cryoport's services have also been instrumental in the global distribution of COVID-19 vaccines, cementing their importance in public health crises.
The company’s comprehensive risk management approach is highlighted by their logistics support for clinical trials and commercial launches. They ensure that biological materials reach their destination safely, utilizing advanced packaging and dedicated logistics centers.
Cryoport, Inc. is part of an innovative and rapidly growing industry that plays a crucial role in a new era of medicine, including cell and gene therapies. With the life sciences landscape continually evolving, Cryoport's services are expected to be increasingly in demand, making the company a significant player in this space. Its commitment to technological innovation and industry-leading customer service make Cryoport a trusted partner for life sciences companies around the globe.
By leveraging advanced technology, environmental sustainability, and rigorous tracking systems, Cryoport, Inc. continually pushes the boundaries of cryogenic logistics. Through innovation and dedicated service, the company remains steadfast in its mission to support the life sciences industry in delivering life-saving therapies to patients worldwide. Their key role in global health logistics firmly establishes them as leaders within the industry.